Can Placental Corticotropin-Releasing Hormone Inform Timing of Antenatal Corticosteroid Administration?
Author(s) -
Danielle A. Swales,
Leah A. Grande,
Deborah A. Wing,
Michelle N. Edelmann,
Laura M. Glynn,
Curt A. Sandman,
Roger Smith,
M.E. Bowman,
Elysia Poggi Davis
Publication year - 2018
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2018-00956
Subject(s) - corticosteroid , administration (probate law) , medicine , corticotropin releasing hormone , hormone , adrenocorticotropic hormone , endocrinology , political science , law
Antenatal corticosteroids are commonly administered to pregnant women at risk for delivering between 23 and 34 gestational weeks; they provide crucial benefits to fetal lung maturation and reduce risk for neonatal morbidity and mortality. Corticosteroids are maximally efficacious for lung maturation when administered within 2 to 7 days of delivery. Accurately identifying the timing of preterm delivery is thus critical to ensure that antenatal corticosteroids are administered within a week of delivery and to avoid unnecessary administration to women who will deliver at term. A plausible biomarker for predicting time of delivery is placental corticotropin-releasing hormone (pCRH).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom